🇺🇸 FDA

Company profile · Sponsor

Laboratorios

Laboratorios Tillomed Spain S.L.U

E89C337 · EMA pharma EU
Pipeline
24
Drugs
0
Patents
0

Quick answer

Laboratorios (E89C337) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 24 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E89C337
Exchange EMA
Company type pharma
Headquarters EU

Pipeline (24)

Search pipeline →

  1. Pred Forte 10 mg/ml colirio en suspensión, Clobetasol propionate ophthalmic nanoemulsion, 0.05%

    Laboratorios

    Inflammation and pain associated with ocular surgery

    phase 3 small molecule active

    1 trial

  2. A RANDOMIZED PHASE I, DOUBLE-BLIND, PARALLEL, COMPARATIVE ASSESSMENT OF PHARMACOKINETICS, SAFETY, PHARMACODYNAMICS, AND IMMUNOGENICITY OF LT-01 (AN OMALIZUMAB BIOSIMILAR CANDIDATE [TEST]) LYOPHYLIZED POWDER FOR SUBCUTANEOUS INJECTION VERSUS EU-APPROVED XOLAIR® LYOPHYLIZED POWDER FOR SUBCUTANEOUS INJECTION (REFERENCE) IN HEALTHY SUBJETCS: CIMA STUDY.

    Laboratorios

    Chronic spontaneous urticaria, Allergic asthma, Chronic rhinosinusitis with nasal polyps

    phase 1 other active

    1 trial

  3. An Open Label Study to Assess the Effect of Patient Use and Robustness on Tiotropium Bromide Spray 2.5μg, Soft Mist Inhaler device

    Laboratorios

    Chronic obstructive pulmonary disease

    phase 1 other active

    1 trial

  4. Bioequivalence clinical trial of dapagliflozin 10 mg tablets, after a single oral dose administration to healthy volunteers under fasting conditions.

    Laboratorios

    Diabetes

    phase 1 other active

    1 trial

  5. Bioequivalence clinical trial of two formulations of linagliptin/metformin

    Laboratorios

    Healthy volunteers

    phase 1 other active

    1 trial

  6. Bioequivalence clinical trial of two formulations of bilastine.

    Laboratorios

    Healthy volunteers

    phase 1 other active

    1 trial

  7. Bioequivalence clinical trial of two formulations of canagliflozin

    Laboratorios

    Healthy volunteers

    phase 1 other active

    1 trial

  8. Bioequivalence clinical trial of two formulations of dapagliflozin.

    Laboratorios

    Healthy volunteers

    phase 1 other active

    1 trial

  9. Bioequivalence clinical trial of two formulations of dapagliflozin/metformin

    Laboratorios

    Healthy volunteers

    phase 1 other active

    1 trial

  10. Bioequivalence clinical trial of two formulations of dapagliflozin/metformin

    Laboratorios

    Healthy volunteers

    phase 1 other active

    1 trial

  11. Bioequivalence clinical trial of two formulations of edoxaban.

    Laboratorios

    Healthy volunteers

    phase 1 other active

    1 trial

  12. Bioequivalence clinical trial of two formulations of ezetimibe/atorvastatin

    Laboratorios

    Healthy volunteers

    phase 1 other active

    1 trial

  13. Bioequivalence clinical trial of two formulations of linagliptin

    Laboratorios

    Healthy volunteers

    phase 1 other active

    1 trial

  14. Bioequivalence clinical trial of two formulations of linagliptin

    Laboratorios

    Healthy volunteers

    phase 1 other active

    1 trial

  15. Bioequivalence clinical trial of two formulations of linagliptin/metformin.

    Laboratorios

    Healthy volunteers

    phase 1 other active

    1 trial

  16. Bioequivalence clinical trial of two formulations of loperamide.

    Laboratorios

    Healthy volunteers

    phase 1 other active

    1 trial

  17. Bioequivalence clinical trial of two formulations of loperamide.

    Laboratorios

    Healthy volunteers

    phase 1 other active

    1 trial

  18. Bioequivalence clinical trial of two formulations of loperamide.

    Laboratorios

    Healthy volunteers

    phase 1 other active

    1 trial

  19. Bioequivalence clinical trial of two formulations of loperamide.

    Laboratorios

    Healthy volunteers

    phase 1 other active

    1 trial

  20. Bioequivalence clinical trial of two formulations of rosuvastatin.

    Laboratorios

    Hypercholesterolemia

    phase 1 other active

    1 trial

  21. Bioequivalence clinical trial of two formulations of vortioxetine.

    Laboratorios

    Healthy volunteers

    phase 1 other active

    1 trial

  22. Bioequivalence of Apixaban 5 mg Film-Coated Tablets in Healthy Subjects Under Fasting Conditions.

    Laboratorios

    No medical condition.

    phase 1 other active

    1 trial

  23. Bioequivalence of Calcifediol monohydrate 0.266 mg Soft Capsules in Healthy Participants Under Fasting Conditions.

    Laboratorios

    No medical condition.

    phase 1 other active

    1 trial

  24. Bioequivalence of Etonogestrel 68 mg Implant in Healthy Pre-Menopausal, Non-Pregnant Female Participants.

    Laboratorios

    No medical condition

    phase 1 other active

    1 trial

Frequently asked questions

What is Laboratorios?

Laboratorios (E89C337) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 24 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Laboratorios sponsor?

We track 24 ClinicalTrials.gov-linked programs for Laboratorios, including Pred Forte 10 mg/ml colirio en suspensión, Clobetasol propionate ophthalmic nanoemulsion, 0.05% and 23 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Laboratorios company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.